Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats

Journal of Alzheimer's Disease : JAD
Xiaojuan WangLiang Li

Abstract

Cerebrovascular hypoperfusion occurs prior to the clinical symptoms of Alzheimer's disease (AD) and represents the most accurate indicator predicting whether an individual develops AD at a future time. To study how cerebrovascular hypoperfusion contributes to AD, we induced cerebrovascular hypoperfusion by bilateral carotid occlusion surgery in adult rats and investigated its impacts on spatial memory, synapses, and accumulation of oligomeric amyloid-β. We found progressive spatial memory deficits, as tested by Morris water maze, starting 30 days after occlusion surgery. The memory deficits were accompanied with decrease in synaptic density and alterations of synaptic ultrastructure in the CA1 area of the hippocampus, as evaluated by electron microscopy. By using immunoelectron microscopy, we also found time-dependent accumulation of oligomeric amyloid-β in the hippocampus, especially in the axonal terminals after chronic cerebrovascular hypoperfusion. Western blot analysis revealed decreased levels of postsynaptic density-95 (PSD-95) and synaptophysin in rat brains after chronic cerebrovascular hypoperfusion. Our findings provide novel insight into the mechanism by which chronic cerebrovascular hypoperfusion contributes to the...Continue Reading

Citations

Jan 6, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·He JiaJun Min Li
Nov 4, 2011·Nature Reviews. Neuroscience·Berislav V Zlokovic
Oct 30, 2014·Cellular and Molecular Neurobiology·Yang Zhao, Cheng-Xin Gong
Mar 17, 2017·Current Hypertension Reports·Keenan A WalkerRebecca F Gottesman
Jul 9, 2013·Journal of Neurotrauma·Niklas MarklundLars Hillered
Oct 28, 2016·Journal of Biomechanical Engineering·Eric S HaldPatrick W Alford
Sep 1, 2017·Dementia and Neurocognitive Disorders·Inha HwangYoungSoon Yang
May 24, 2014·Expert Review of Neurotherapeutics·Henrik Zetterberg, Niklas Mattsson
Jun 28, 2014·Molecular Medicine Reports·Shuifen YeJing Cai
Sep 6, 2014·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Akira NakajimaKiyofumi Yamada
Feb 13, 2013·Neurotoxicity Research·Mak Adam Daulatzai
Aug 14, 2020·Pflügers Archiv : European journal of physiology·Hermann Koepsell
Oct 17, 2014·Pharmaceutical Research·Dharmini C MehtaJoseph A Nicolazzo
Sep 1, 2020·Acta Neuropathologica·Nils KorteDavid Attwell
Mar 12, 2015·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yasushi Ohizumi
Sep 7, 2018·Experimental and Therapeutic Medicine·Xiaowen YuXiping Tuo
Dec 14, 2018·International Journal of Molecular Sciences·Ryszard PlutaStanisław J Czuczwar
Jan 18, 2020·International Journal of Molecular Sciences·Marzena Ułamek-KoziołRyszard Pluta
Aug 12, 2020·Nature Neuroscience·Marc Aurel Busche, Bradley T Hyman
Jul 1, 2020·Journal of Alzheimer's Disease : JAD·Ernesto SolisErin R Hascup
Apr 5, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Chenghan WuUNKNOWN Yangxue Qingnao Granule CHRONIC CEREBRAL HYPOPERFUSION STUDY GROUP
Jul 11, 2018·Frontiers in Molecular Neuroscience·Michelle E WattsCharles Claudianos
Nov 16, 2018·Neurotoxicity Research·Amanda Nunes SantiagoRúbia Maria Weffort de Oliveira
Apr 5, 2018·Journal of Alzheimer's Disease : JAD·Ingmar SkoogKaj Blennow
Sep 25, 2012·Acta Anaesthesiologica Scandinavica·B ReinsfeltS-E Ricksten
Aug 10, 2019·Frontiers in Neuroscience·Ximena CastilloMarietta Zille
Feb 6, 2021·Brain Communications·Graham M L EglitKatherine J Bangen
Mar 4, 2021·Acta Physiologica·Kewarin JinawongSiriporn C Chattipakorn
Apr 4, 2021·International Journal of Molecular Sciences·Mercedes UnzetaMontse Solé
Jun 3, 2021·International Journal of Molecular Sciences·Federico Paolini PaolettiLorenzo Gaetani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.